TEE
CDNA icon

Tibra Equities Europe’s CareDx CDNA Stock Holding History

Tibra Equities Europe’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,500
Closed -$464K – 202
2019
Q3 		$464K Buy
+20,500
New +$568K 0.06% 162
2018
Q2 		– Sell
-48,604
Closed -$387K – 132
2018
Q1 		$387K Buy
+48,604
New +$300K 0.07% 149

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Tibra Equities Europe's CDNA Position: Q4 2019 in Review

Tibra Equities Europe sold out of CareDx (CDNA) in Q4 2019, closing a stake of 20,500 shares — an estimated $464K sold.

Tibra Equities Europe first reported a position in CDNA in Q1 2018 and held it in 2 quarters. The position peaked at $464K in Q3 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

  • Tibra Equities Europe reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 20,500 CareDx shares in Q4 2019, an estimated $464K.
  • Tibra Equities Europe first reported a position in CareDx in Q1 2018 and held it in 2 quarters.
  • Tibra Equities Europe's CareDx position peaked at $464K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Tibra Equities Europe's 13F filing for Q4 2019, filed 14 Feb 2020.